# A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors

> **NCT05594875** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 9 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** SHR-1921

## Key facts

- **NCT ID:** NCT05594875
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2024-04-24
- **Final completion:** 2024-04-24
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05594875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05594875, "A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT05594875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*